Common misperceptions and realities - Unlock the truth about market access in Central and Eastern Europe
Despite rapid healthcare system evolution and strong economic fundamentals, CEE markets are often overlooked or misunderstood by global pharma teams. This expert-authored whitepaper challenges six common myths about pricing and market access in the region - revealing why now is the time to rethink your strategy.
Backed by data and real-world comparisons with EU-4 markets, it offers clear, actionable insights without overwhelming detail.
Ideal for market access, pricing, and commercial leaders looking to unlock growth where others see complexity.
